🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
39.24
+0.31 (0.80%)
Nov 20, 2026, 2:38 PM EST - Market open

CRISPR Therapeutics AG Statistics

Total Valuation

CRSP has a market cap or net worth of $3.81 billion. The enterprise value is $2.31 billion.

Market Cap3.81B
Enterprise Value 2.31B

Important Dates

The last earnings date was Monday, November 2, 2026, before market open.

Earnings Date Nov 2, 2026
Ex-Dividend Date n/a

Share Statistics

CRSP has 97.00 million shares outstanding. The number of shares has increased by 9.95% in one year.

Current Share Class 97.00M
Shares Outstanding 97.00M
Shares Change (YoY) +9.95%
Shares Change (QoQ) +0.24%
Owned by Insiders (%) 0.52%
Owned by Institutions (%) 78.92%
Float 96.49M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 152.56
Forward PS 77.08
PB Ratio 2.29
P/TBV Ratio 2.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 93.10
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 16.21, with a Debt / Equity ratio of 0.47.

Current Ratio 16.21
Quick Ratio 16.12
Debt / Equity 0.47
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -25.60% and return on invested capital (ROIC) is -322.56%.

Return on Equity (ROE) -25.60%
Return on Assets (ROA) -13.49%
Return on Invested Capital (ROIC) -322.56%
Return on Capital Employed (ROCE) -21.45%
Weighted Average Cost of Capital (WACC) 12.21%
Revenue Per Employee $64,051
Profits Per Employee -$1.16M
Employee Count393
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, CRSP has paid $2.49 million in taxes.

Income Tax 2.49M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -21.80% in the last 52 weeks. The beta is 1.90, so CRSP's price volatility has been higher than the market average.

Beta (5Y) 1.90
52-Week Price Change -21.80%
50-Day Moving Average 50.72
200-Day Moving Average 52.28
Relative Strength Index (RSI) 30.05
Average Volume (20 Days) 2,051,215

Short Selling Information

The latest short interest is 17.19 million, so 17.72% of the outstanding shares have been sold short.

Short Interest 17.19M
Short Previous Month 16.44M
Short % of Shares Out 17.72%
Short % of Float 17.81%
Short Ratio (days to cover) 11.65

Income Statement

In the last 12 months, CRSP had revenue of $25.17 million and -$456.14 million in losses. Loss per share was -$4.75.

Revenue25.17M
Gross Profit -447.18M
Operating Income -518.18M
Pretax Income -453.65M
Net Income -456.14M
EBITDA -499.68M
EBIT -518.18M
Loss Per Share -$4.75
Full Income Statement

Balance Sheet

The company has $2.27 billion in cash and $779.83 million in debt, with a net cash position of $1.50 billion or $15.43 per share.

Cash & Cash Equivalents 2.27B
Total Debt 779.83M
Net Cash 1.50B
Net Cash Per Share $15.43
Equity (Book Value) 1.65B
Book Value Per Share 17.02
Working Capital 2.14B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$374.63 million and capital expenditures -$2.08 million, giving a free cash flow of -$376.72 million.

Operating Cash Flow -374.63M
Capital Expenditures -2.08M
Depreciation & Amortization 18.50M
Net Borrowing 600.00M
Free Cash Flow -376.72M
FCF Per Share -$3.88
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -2,058.55%
Pretax Margin -1,802.19%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRSP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -9.95%
Shareholder Yield -9.95%
Earnings Yield -12.10%
FCF Yield -9.81%

Analyst Forecast

The average price target for CRSP is $85.42, which is 117.69% higher than the current price. The consensus rating is "Buy".

Price Target $85.42
Price Target Difference 117.69%
Analyst Consensus Buy
Analyst Count 23
Revenue Growth Forecast (3Y) 456.52%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CRSP has an Altman Z-Score of 2.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.57
Piotroski F-Score 1